186 related articles for article (PubMed ID: 34915486)
1. Hypogonadism in Male Infants and Adolescents: New Androgen Formulations.
Chioma L; Cappa M
Horm Res Paediatr; 2023; 96(6):581-589. PubMed ID: 34915486
[TBL] [Abstract][Full Text] [Related]
2. Androgens During Infancy, Childhood, and Adolescence: Physiology and Use in Clinical Practice.
Mason KA; Schoelwer MJ; Rogol AD
Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32115641
[TBL] [Abstract][Full Text] [Related]
3. Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach.
Stancampiano MR; Lucas-Herald AK; Russo G; Rogol AD; Ahmed SF
Horm Res Paediatr; 2019; 92(4):215-228. PubMed ID: 31851967
[TBL] [Abstract][Full Text] [Related]
4. Androgen therapy in hypogonadal adolescent males.
Bertelloni S; Baroncelli GI; Garofalo P; Cianfarani S
Horm Res Paediatr; 2010; 74(4):292-296. PubMed ID: 20938205
[TBL] [Abstract][Full Text] [Related]
5. Testosterone Use in Adolescent Males: Current Practice and Unmet Needs.
Vogiatzi M; Tursi JP; Jaffe JS; Hobson S; Rogol AD
J Endocr Soc; 2021 Jan; 5(1):bvaa161. PubMed ID: 33294762
[TBL] [Abstract][Full Text] [Related]
6. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism.
Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E
J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803
[TBL] [Abstract][Full Text] [Related]
7. Male pubertal development and the role of androgen therapy.
Richmond EJ; Rogol AD
Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):338-44. PubMed ID: 17377616
[TBL] [Abstract][Full Text] [Related]
8. Androgen Treatment in Adolescent Males With Hypogonadism.
Rey RA; Grinspon RP
Am J Mens Health; 2020; 14(3):1557988320922443. PubMed ID: 32448030
[TBL] [Abstract][Full Text] [Related]
9. Emerging medication for the treatment of male hypogonadism.
Aydogdu A; Swerdloff RS
Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations.
Giagulli VA; Triggiani V; Corona G; Carbone D; Licchelli B; Tafaro E; Resta F; Sabbà C; Maggi M; Guastamacchia E
Curr Pharm Des; 2011; 17(15):1500-11. PubMed ID: 21521164
[TBL] [Abstract][Full Text] [Related]
11. New facets of androgen replacement therapy during childhood and adolescence.
Rogol AD
Expert Opin Pharmacother; 2005 Jul; 6(8):1319-36. PubMed ID: 16013983
[TBL] [Abstract][Full Text] [Related]
12. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
13. Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated.
Bin-Abbas B; Conte FA; Grumbach MM; Kaplan SL
J Pediatr; 1999 May; 134(5):579-83. PubMed ID: 10228293
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
[TBL] [Abstract][Full Text] [Related]
15. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
16. Pubertal androgen therapy in boys.
Rogol AD
Pediatr Endocrinol Rev; 2005 Mar; 2(3):383-90. PubMed ID: 16429115
[TBL] [Abstract][Full Text] [Related]
17. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy--what, when and to whom?
Jockenhövel F
Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128
[TBL] [Abstract][Full Text] [Related]
19. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
20. Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety.
Honig S; Gittelman M; Kaminetsky J; Wang C; Amory JK; Rohowsky N; Dudley RE; Woun Seo B; Newmark J; Swerdloff R
J Sex Med; 2022 Dec; 19(12):1750-1758. PubMed ID: 36272969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
